NCT00783367 · Interventional trial
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Overall registry status Completed
Phase 2
Conditions Follicular Lymphoma, Lymphoma of Mucosa-Associated Lymphoid Tissue, Lymphoma, Small Lymphocytic, MALT Lymphoma, Mantle-Cell Lymphoma, Marginal Zone B-Cell Lymphoma, Waldenstrom Macroglobulinemia
Delaware Valley sites
- University of Pennsylvania; Abramson Cancer Center; Lymphoma Program · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory